Exploring the prognostic and therapeutic utility of expanded mutation profiling in appendix peritoneal metastasis managed with CRS/HIPEC-Reference-Cited by-同舟云学术

Exploring the prognostic and therapeutic utility of expanded mutation profiling in appendix peritoneal metastasis managed with CRS/HIPEC

Published:2021-03-05 Issue:7 Volume:123 Page:1599-1609
ISSN:0022-4790
Container-title:Journal of Surgical Oncology
language:en
Short-container-title:J Surg Oncol

Author:

Zhang Chunmeng¹^ORCID,Plambeck Benjamin D.¹,Craig Margaret E.¹,Tu Alexander¹,Mikus Ryan J¹,Shostrom Valerie²,McDermott Sean P.¹,Igbinigie Ikponmwosa¹,Brown Krista³,Cushman‐Vokoun Allison⁴,Foster Jason M.¹

Affiliation:

1. Division of Surgical Oncology, Department of Surgery University of Nebraska Medical Center Omaha Nebraska USA

2. Department of Biostatistics University of Nebraska Medical Center Omaha Nebraska USA

3. Department of Epidemiology University of Nebraska Medical Center Omaha Nabraska USA

4. Department of Pathology University of Nebraska Medical Center Omaha Nebraska USA

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jso.26439

Reference33 articles.

1. Appendiceal neoplasms and pseudomyxoma peritonei: a population based study;Smeenk RM;Eur J Surg Oncol,2008

2. The histopathological classification, diagnosis and differential diagnosis of mucinous appendiceal neoplasms, appendiceal adenocarcinomas and pseudomyxoma peritonei;Carr NJ;Histopathology,2017

3. Peritoneal carcinomatosis from non‐gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study;Sadeghi B;Cancer,2000

4. New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome?;Sugarbaker PH;Lancet Oncol,2006

5. The Delphi and GRADE methodology used in the PSOGI 2018 consensus statement on pseudomyxoma peritonei and peritoneal mesothelioma;Lurvink RJ;Eur J Surg Oncol,2021

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of RAS and BRAF mutations on peritoneal metastasis risk and cytoreductive surgery/hyperthermic intraperitoneal chemotherapy efficacy in colorectal cancer: A systematic review and meta-analysis;European Journal of Surgical Oncology;2024-09

2. Mutational profiles and prognostic impact in colorectal and high‐grade appendiceal adenocarcinoma with peritoneal metastases;Journal of Surgical Oncology;2023-01-12

3. Peritoneal metastases from primary appendiceal and colorectal carcinomas demonstrate distinct molecular identities on comprehensive tumor analysis;Journal of Surgical Oncology;2023-01-11

4. The contemporary management of peritoneal metastasis: A journey from the cold past of treatment futility to a warm present and a bright future;CA: A Cancer Journal for Clinicians;2022-08-15